<SEC-DOCUMENT>0001213900-24-075083.txt : 20240903
<SEC-HEADER>0001213900-24-075083.hdr.sgml : 20240903
<ACCEPTANCE-DATETIME>20240903161308
ACCESSION NUMBER:		0001213900-24-075083
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240903
DATE AS OF CHANGE:		20240903

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ParaZero Technologies Ltd.
		CENTRAL INDEX KEY:			0001916241
		STANDARD INDUSTRIAL CLASSIFICATION:	AIRCRAFT PART & AUXILIARY EQUIPMENT, NEC [3728]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275351
		FILM NUMBER:		241274190

	BUSINESS ADDRESS:	
		STREET 1:		1 HATACHANA STREET
		CITY:			KFAR SABA
		STATE:			L3
		ZIP:			4453001
		BUSINESS PHONE:		97236885252

	MAIL ADDRESS:	
		STREET 1:		1 HATACHANA STREET
		CITY:			KFAR SABA
		STATE:			L3
		ZIP:			4453001
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>ea0212120-posam2_parazero.htm
<DESCRIPTION>POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 ON FORM F-3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As filed with the Securities and Exchange
Commission on September 3, 2024.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No.&nbsp;333-275351</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.25in"></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>POST-EFFECTIVE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
NO. 2</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
F-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>ON</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>FORM F-3</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF&nbsp;1933</B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ParaZero Technologies&nbsp;Ltd.</B><BR>
<I>(Exact name of registrant as specified in its charter)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1pt; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State&nbsp;of&nbsp;Israel</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3728</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1pt; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not&nbsp;Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State&nbsp;or&nbsp;other&nbsp;jurisdiction&nbsp;of
    incorporation&nbsp;or&nbsp;organization)</I></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary&nbsp;Standard&nbsp;Industrial
    Classification&nbsp;Code&nbsp;Number)</I></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S.&nbsp;Employer
    </I><BR>
    <I>Identification&nbsp;Number)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> <B>1
                           HaTachana St.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> <B>Kfar Saba, Israel
4453001<BR>
Tel: +972-50-275-3666</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address,
including zip code, and telephone<BR>
number, including area code, of registrant&rsquo;s<BR>
principal executive offices)</I></FONT> </P></TD>
    <TD STYLE="white-space: nowrap; width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Puglisi&nbsp;&amp;
                           Associates<BR>
                           850 Library Ave., Suite 204<BR>
                           Newark, DE&nbsp;19711<BR>
                           Tel: 302.738.6680</B></FONT> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Name,
    address, including zip code, and<BR>
    telephone&nbsp;number,&nbsp;including&nbsp;area&nbsp;code,&nbsp;of&nbsp;agent<BR>
    for service)</I></FONT> </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Copies to:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David Huberman,
    Esq. <BR>
    Greenberg Traurig, P.A<BR>
    One Azrieli Center<BR>
    Round Tower, 30<SUP>th</SUP> floor<BR>
    132 Menachem Begin Rd <BR>
    Tel Aviv 6701101<BR>
    Telephone: +972 (0) 3.636.6000</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shy Baranov,
    Adv. <BR>
    Gornitzky&nbsp;&amp; Co.</B> <BR>
    <B>Vitania Tel Aviv Tower</B> <BR>
    <B>20&nbsp;HaHarash Street</B> <BR>
    <B>Tel Aviv, 6761310 <BR>
    Israel Tel: +972 (3)&nbsp;710.9191</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public: </B>As soon as practicable after the effective date hereof.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under
the Securities Act, check the following box. &#9746;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act, check
the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this form is a post-effective amendment filed pursuant to Rule&nbsp;462(c)&nbsp;under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this form is a post-effective amendment filed pursuant to Rule&nbsp;462(d)&nbsp;under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule&nbsp;405 of the Securities Act&nbsp;of&nbsp;1933.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company &#9746;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S.&nbsp;GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards &dagger; provided
pursuant to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act. &#9744;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            term &ldquo;new or revised financial accounting standard&rdquo; refers to any update issued
                                            by the Financial Accounting Standards Board to its Accounting Standards Codification after
                                            April&nbsp;5, 2012.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section&nbsp;8(a)&nbsp;of the Securities Act or until the registration statement shall become effective on such date
as the Commission, acting pursuant to said Section&nbsp;8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXPLANATORY
NOTE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ParaZero
Technologies Ltd., or the Registrant, filed with the Securities and Exchange Commission, or the SEC, a Registration on Form F-1 (Registration
No. 333-375351) on November 6, 2023, which was declared effective by the SEC on November 15, 2023, or the Registration Statement. The
Registration Statement originally covered the resale from time to time by the selling shareholders identified in the prospectus that
form a part of the Registration Statement of up to 14,836,366 ordinary shares, par value NIS 0.02 per share, or Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> On March 21, 2024,
the Registrant filed Post-Effective Amendment No. 1 to update and supplement information contained in the Registration Statement, and
also to include updated financial information. Post-Effective Amendment No. 1 was declared effective by the Securities and Exchange Commission
on March 22, 2024. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> This Post-Effective Amendment No. 2 is being
filed by the Registrant to update and supplement information contained in the Registration Statement, and also to include updated financial
information as well as to convert the Registration Statement on Form F-1 into a registration statement on Form F-3. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
additional securities are being registered under this Post-Effective Amendment No. 2. This Post Effective Amendment No. 2 concerns only
the sale of the Ordinary Shares by the Selling Shareholders from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
filing fees payable in connection with the registration of these securities were previously paid in connection with the initial filing
of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. The selling shareholders may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and
is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; width: 35%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>PROSPECTUS</B></FONT> </TD>
    <TD STYLE="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT> </TD>
    <TD STYLE="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; width: 30%; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT&nbsp;TO&nbsp;COMPLETION</B></FONT> </TD>
    <TD STYLE="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT> </TD>
    <TD STYLE="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; width: 33%; text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="text-transform: uppercase; color: Red"><B>DATED
                                            <FONT STYLE="text-transform: uppercase">SEPTEMBER 3</FONT>,&nbsp;2024</B></FONT> </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4,636,364
Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> &nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ParaZero
    Technologies&nbsp;Ltd.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the resale, by the selling shareholders identified in this prospectus, of up to 4,636,364 ordinary shares, par
value NIS 0.02 per share, or Ordinary Shares, of ParaZero Technologies Ltd. issuable upon the exercise of Series A warrants, or the Series
A Warrants as further described below under &ldquo;Prospectus Summary&nbsp;&mdash;&nbsp;&nbsp;October 2023 Private Placement&rdquo;.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling shareholders are identified in the table commencing on page 12. No Ordinary Shares are being registered hereunder for
sale by us. We will not receive any proceeds from the sale of the Ordinary Shares by the selling shareholders. All net proceeds from
the sale of the Ordinary Shares covered by this prospectus will go to the selling shareholders. We may receive cash proceeds equal to
the total exercise price of warrants that are exercised for cash, of approximately $5.1 million, based on an exercise price of $1.10
per share and subject to adjustments, if all warrants are exercised. See &ldquo;Use of Proceeds.&rdquo; The selling shareholders may
sell all or a portion of the Ordinary Shares from time to time in market transactions through any market on which our Ordinary Shares
are then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined by the then prevailing market
price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal or by a combination of such
methods of sale. See &ldquo;Plan of Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Our Ordinary Shares are listed on the Nasdaq
Capital Market, or the Nasdaq, under the symbol &ldquo;PRZO.&rdquo; The last reported sale price of our Ordinary Shares on Nasdaq on
August 30, 2024, was $0.553&nbsp;per share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are both an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and a &ldquo;foreign
private issuer,&rdquo; as defined under the U.S. federal securities laws and are subject to reduced public company reporting requirements.
See &ldquo;Prospectus Summary &mdash; Implications of Being an Emerging Growth Company and a Foreign Private Issuer&rdquo; for additional
information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk.&nbsp;See &ldquo;Risk Factors&rdquo; beginning on page 8.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission (or the SEC), nor any state or other foreign securities commission has approved nor disapproved
these securities or determined if this prospectus is truthful or complete.&nbsp;Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-left: 0.125in; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAGE</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLING SHAREHOLDERS</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in">12</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SHARE CAPITAL</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in">14</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in">20</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in">22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ENFORCEMENT OF CIVIL LIABILITIES</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE
YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0.125in">24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_014">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 0.125in">24</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
This Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus and any free writing prospectus prepared by or on behalf of us or to
which we have referred you. Neither we nor the selling shareholders have authorized anyone to provide you with different information.
Neither we nor the selling shareholders are offering to sell the Ordinary Shares, nor we are seeking offers to buy the Ordinary Shares,
at any jurisdictions where offers and sales are not permitted. The information in this prospectus is accurate only as of the date of
this prospectus, regardless of the time of delivery of this prospectus or any sale of the Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investors outside of the United&nbsp;States: Neither we nor the selling shareholders have done anything that would permit this offering
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United&nbsp;States.
You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms &ldquo;shekel,&rdquo; &ldquo;Israeli shekel&rdquo; and &ldquo;NIS&rdquo; refer to New Israeli Shekels, the lawful currency of the
State of Israel, and the terms &ldquo;dollar,&rdquo; &ldquo;U.S.&nbsp;dollar&rdquo; or &ldquo;$&rdquo; refer to United&nbsp;States dollars,
the lawful currency of the United&nbsp;States of America. All references to &ldquo;shares&rdquo; in this prospectus refer to Ordinary
Shares of ParaZero Technologies Ltd., par value NIS 0.02 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRADEMARKS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ParaZero,&rdquo;
&ldquo;SafeAir,&rdquo; &ldquo;SmartAir,&rdquo; &ldquo;SmartAir Pro&rdquo; and &ldquo;TerminateAir&rdquo; are trademarks of ours that
we use in this prospectus. This prospectus also includes trademarks, tradenames and service marks that are the property of other organizations.
Solely for convenience, our trademarks and tradenames referred to in this prospectus appear without the &reg; or &trade; symbols, but
those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights,
or the right of the applicable licensor to our trademark and tradenames.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MARKET,
INDUSTRY AND OTHER DATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains estimates, projections and other information concerning our industry, our business, and the markets for our product
candidates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject
to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information.
Unless otherwise expressly stated, we obtained this industry, business, market and other data from our own internal estimates and research
as well as from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry
and general publications, government data and similar sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, assumptions and estimates of our and our industry&rsquo;s future performance are necessarily subject to a high degree of uncertainty
and risk due to a variety of factors, including those described in &ldquo;Risk Factors.&rdquo; These and other factors could cause our
future performance to differ materially from our assumptions and estimates. See &ldquo;Special Note&nbsp;Regarding Forward-Looking Statements.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
                                            SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights selected information contained elsewhere in or incorporated by reference into this prospectus and does not contain
all of the information that you should consider in making your investment decision. Before deciding to invest in our securities, you
should read this entire prospectus carefully, including the sections of this prospectus entitled &ldquo;Risk Factors&rdquo; and our consolidated
financial statements and the related notes incorporated by reference into this prospectus and the other documents incorporated by reference
into this prospectus, which are described under &ldquo;Incorporation of Certain Information by Reference&rdquo; before making an investment
in our securities. Unless the context otherwise requires, references in this prospectus to the &ldquo;company,&rdquo; &ldquo;ParaZero,&rdquo;
&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; and other similar designations refer to ParaZero Technologies Ltd.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing
what we believe are best-in-class autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems, or
UAS.&nbsp;Our company was founded by a group of aviation professionals, together with veteran drone operators, to address the drone industry&rsquo;s
safety challenges. Our goal is to enable the drone industry to realize its greatest potential through increasing safety and mitigating
operational risk.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drones
are either navigated manually with a remote control or operated autonomously by software. Drones have long seen widespread use in the
military for surveillance and long-range attack purposes and have also been used for weather monitoring and search and rescue operations.
As developments in the mobile industry have enabled manufacturers to decrease the size, weight, and cost of batteries and cameras, the
drone industry has expanded beyond its largely military-based origins and scale for commercial and civil government use cases. Increased
automation of drones and a global concern for sustainability have also driven demand. Drones have become an integral workflow tool among
a myriad of global industries and have a wide array of commercial applications, such as photography, agriculture, package delivery, first
response/public safety, surveying, construction site monitoring, and infrastructure inspection. Drones are easy enough even for private
individuals to maintain and operate and do not require expensive infrastructure, allowing for recreational use. As demand and use cases
for commercial drones have increased, so too have concerns over drone safety, and we believe our safety solutions place us in a strong
position to take advantage of the developing market and regulatory frameworks, which are increasingly recognizing parachute recovery
systems as effective forms of risk mitigation for expanded operational approvals across an increasing number of global regions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> Our unique, patented technology enables
parachute deployment on drones in a fraction of a second using an autonomous computer paired with a ballistic parachute launcher. We
believe that we have created a new benchmark in drone safety with low altitude parachute deployment capabilities and high levels of reliability.
Globally, our solutions have proven critical to enabling commercial drone operations in over populated areas and beyond-visual-line-of-sight,
which require prior approval from aviation regulators, including the U.S., Canada, Israel, Brazil, Singapore, Australia, Ireland and
the U.K., among other countries. These authorizations facilitate new business opportunities and applications for expanded drone operations
worldwide, thus enhancing the value proposition of our solutions for our global customers. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The Company does not rely on licensing partners
and licensees but instead relies on sale, collaboration and other arrangements with third-party service providers, vendors and development
partners that purchase the Company&rsquo;s products and then seek regulatory approval for the combined use of their drones with the Company&rsquo;s
products. The Company has no licensing agreements or arrangements with, and does not receive any royalty payments from, any parties,
except for one license agreement for the out-license of software previously developed by the Company for the production of its hardware,
which has generated an immaterial amount of revenue. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
unique, patented technology for drones, the SafeAir system, is designed to protect hardware, people, and payload in the event of an in-flight
failure. The SafeAir system is a smart parachute system that monitors UAS flight in real time, identifies critical failures and autonomously
triggers a parachute in the event of an emergency. The system contains a flight termination system, a black box to enable post-deployment
analysis, and a warning buzzer to alert people of a falling drone. In addition to being fully autonomous, the SafeAir system includes
a separate remote control for manual parachute deployment capability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> We have a global distribution footprint
and have forged partnerships all around the world, including India, South Korea, the United States, Latin America and Europe. We sell
our drone safety systems as off-the-shelf solutions, as well as perform integrations with OEMs, offering customized, bespoke safety solutions
for a large variety of aerial platforms, including multi-rotor, fixed wing, vertical take-off and landing, heavy lift, and urban air
mobility. Our technology has been sold to and used by some of the world&rsquo;s top companies and organizations, including drone companies
such as LIFT Aircraft, Airobotics, SpeedBird Aero and Doosan Corporation and other leading and known brands and entities such as CNN,
the New York Times, Hensel Phelps, Verizon Media (Skyward), Fox Television Station, the Chicago Police Department and Fortis Construction.&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
</div>
<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> In
                                            February 2024, we announced our intention to enter the counter unmanned aircraft system (anti-drone),
                                            or C-UAS, market. Small, lethal drones are being utilized around the world with tremendous
                                            effectiveness and are reshaping the balance between humans and technology, especially in
                                            wars, raising the demand for C-UAS countermeasures. Counter-drone technology encompasses
                                            a wide range of solutions that allow users to detect, classify, and mitigate drones and unmanned
                                            aerial vehicles. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> Many of the current C-UAS
solutions offer communication jamming, or COMJAM, of radio frequencies. Drone jamming equipment is designed to block signals on operating
bands and/or navigation causing drones to attempt to return to their take-off point, stop in midair or land. COMJAM is considered the
first layer of drone defense. In cases where a drone is not affected by the COMJAM, a second layer of defense will take place. For the
second layer of defense, there are currently different approaches, technologies, and solutions. This second layer of defense usually
consists of a physical counter measure, such as shooting at the targeted drone, firing missiles and other guided munitions and other
solutions aimed at physically damaging or capturing a drone in the sky. We believe that we can use our current patents and technology
as a basis for the development of a second layer of defense solution that will physically stop drones in the sky in cases where the COMJAM
is not effective or successful. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> The current war between
Russia and Ukraine and Israel&rsquo;s war against terrorism demonstrate the threat of small drones on armies, strategic facilities, and
critical infrastructure. According to Fortune Business Insight, the global anti-drone market size was valued at USD 1.58 billion in 2022
and is expected to grow to USD 6.95 billion by 2029, an opportunity which we seek to seize. </P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"></P>


</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>October&nbsp;2023
Private Placement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October&nbsp;26, 2023, we entered into a&nbsp;private&nbsp;placement&nbsp;transaction, or the October&nbsp;2023 Private Placement, pursuant
to a securities purchase agreement, or the October&nbsp;2023 PIPE Agreement, with certain accredited investors, or the Purchasers, for
aggregate gross proceeds of $5.1&nbsp;million, before deducting fees to the placement agent and other expenses payable by us in connection
with the&nbsp;October&nbsp;2023 Private&nbsp;Placement. The&nbsp;October&nbsp;2023 Private&nbsp;Placement closed on October&nbsp;30,
2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the&nbsp;October&nbsp;2023 Private&nbsp;Placement, we issued units and pre-funded units, collectively, the Units, consisting
of an aggregate of (i)&nbsp;1,136,364&nbsp;Ordinary Shares, (ii)&nbsp;3,500,000 pre-funded warrants each to purchase one Ordinary Share,
or the Pre-Funded Warrants, (iii)&nbsp;4,636,364 series A warrants each to purchase one Ordinary Share, or the Series&nbsp;A Warrants,
and (iv)&nbsp;series B warrants to purchase a maximum amount of 5,563,638&nbsp;Ordinary Shares, or the Series&nbsp;B Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Unit consisted of (i)&nbsp;one Ordinary Share or Pre-Funded Warrant, (ii)&nbsp;one Series&nbsp;A Warrant and (iii)&nbsp;one Series&nbsp;B
Warrant. The purchase price was $1.10 per Unit. The Pre-Funded Warrants were immediately exercisable at an exercise price of $0.005 per
Ordinary Share and have been exercised in full. The Series&nbsp;A Warrants are immediately exercisable, have an exercise price of $1.10
per Ordinary Share (subject to customary adjustments and certain anti-dilution protection) and have a term of 5.5&nbsp;years from the
date of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the end of an adjustment period, the aggregate number of Ordinary Shares issuable upon the exercise of the Series B Warrant was determined
to be 140,373 Ordinary Shares, which is based on a Reset Price (as defined in the Series B Warrant) of $1.0677, calculated as the arithmetic
average of the sum of the thirty-six volume weighted average prices of the Ordinary Shares during the applicable Reset Period (as defined
in the Series B Warrant). As of the date of this prospectus, the Series B Warrants have been exercised in full.</FONT></P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
                                            Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our securities involves substantial risk. The risks described under the heading &ldquo;Risk Factors&rdquo; immediately following this
summary and other risk factors contained in the documents incorporated by reference may cause us to not realize the full benefits of
our strengths or may cause us to be unable to successfully execute all or part of our strategy. Some of the more significant challenges
include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are a development-stage company and have a limited operating history on which to assess the
                                            prospects for our business, have incurred significant losses since the date of our inception,
                                            and anticipate that we will continue to incur significant losses until we are able to successfully
                                            commercialize our products.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have not generated any significant revenue from the sale of our current products and may
                                            never be profitable.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            expect that we will need to raise substantial additional capital before we can expect to
                                            become profitable from sales of our products. This additional capital may not be available
                                            on acceptable terms, or at all. Failure to obtain this necessary capital when needed may
                                            force us to delay, limit or terminate our product development efforts or other operations.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            financial statements contain an explanatory paragraph regarding substantial doubt about our
                                            ability to continue as a going concern, which could prevent us from obtaining new financing
                                            on reasonable terms or at all.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company expects to incur substantial research and development costs and devote significant
                                            resources to identifying and commercializing new products and services, which could significantly
                                            reduce its profitability and may never result in revenue to the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we fail to comply with
    the continued listing requirements of the Nasdaq Capital Market, our ordinary shares may be delisted and the price of our ordinary
    shares and our ability to access the capital markets could be negatively impacted.</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            headquarters, research and development and other significant operations are located in Israel,
                                            and, therefore, our results may be adversely affected by political, economic and military
                                            instability in Israel including the recent war with Hamas and other terrorist organizations
                                            from the Gaza Strip.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> We are an Israeli corporation based in Israel
and were incorporated on June&nbsp;30, 2013, under the name ParaZero Ltd. On September&nbsp;6, 2018, our name was changed to ParaZero
Israel Ltd., and on November&nbsp;4, 2018, our name was changed to our current name, ParaZero Technologies Ltd. Our principal executive
offices are located at 1 HaTachana St., Kfar Saba, Israel 4453001. Our telephone number in Israel is +972-50-275-3666. Our website address
is&nbsp;<I>www.parazero.com</I>. The information contained on our website and available through our website is not incorporated by reference
into and should not be considered a part of this prospectus, and the reference to our website in this prospectus is an inactive textual
reference only. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"></P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
                                            of Being an &ldquo;Emerging Growth Company&rdquo; and a &ldquo;Foreign Private Issuer&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Emerging
Growth Company</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company with less than $1.235&nbsp;billion in revenue during our last fiscal year, we qualify as an &ldquo;emerging growth company&rdquo;
as defined in the Jumpstart Our Business Startups Act&nbsp;of&nbsp;2012, or the JOBS Act. An emerging growth company may take advantage
of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. In particular, as an emerging
growth company, we:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            present only two&nbsp;years of audited financial statements and only two&nbsp;years of related
                                            Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations
                                            disclosure in our initial registration statement;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
                                            not required to provide a detailed narrative disclosure discussing our compensation principles,
                                            objectives and elements and analyzing how those elements fit with our principles and objectives,
                                            which is commonly referred to as &ldquo;compensation discussion and analysis&rdquo;;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
                                            not required to obtain a non-binding advisory vote from our shareholders on executive compensation
                                            or golden parachute arrangements (commonly referred to as the &ldquo;say-on-pay,&rdquo; &ldquo;say-on
                                            frequency&rdquo; and &ldquo;say-on-golden-parachute&rdquo; votes);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">will
                                            not be required to conduct an evaluation of our internal control over financial reporting;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
                                            exempt from certain executive compensation disclosure provisions requiring a pay-for-performance
                                            graph and chief executive officer pay ratio disclosure; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
                                            exempt from the auditor attestation requirement in the assessment of our internal control
                                            over financial reporting pursuant to the Sarbanes-Oxley Act&nbsp;of&nbsp;2002.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may take advantage of these provisions for up to five&nbsp;years or such earlier time that we are no longer an emerging growth company.
We would cease to be an emerging growth company upon the earlier to occur of: (1)&nbsp;the last&nbsp;day of the fiscal year in which
we have total annual gross revenues of $1.235&nbsp;billion or more; (2)&nbsp;the date on which we have issued more than $1.0&nbsp;billion
in nonconvertible debt during the previous three&nbsp;years; or (3)&nbsp;the date on which we are deemed to be a large accelerated filer
under the rules of the Securities and Exchange Commission, or the SEC.&nbsp;We may choose to take advantage of some but not all of these
reduced burdens, and therefore the information that we provide holders of our Ordinary Shares may be different than the information you
might receive from other public companies in which you hold equity. In addition, Section&nbsp;107 of the JOBS Act also provides that
an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards
applicable to public companies. We have elected to take advantage of the extended transition period to comply with new or revised accounting
standards and to adopt certain of the reduced disclosure requirements available to emerging growth companies. As a result of the accounting
standards election, we will not be subject to the same implementation timing for new or revised accounting standards as other public
companies that are not emerging growth companies which may make comparison of our financials to those of other public companies more
difficult.&nbsp;In addition, the information that we provide in this prospectus may be different than the information you may receive
from other public companies in which you hold equity interests.</FONT></P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
                                            Private Issuer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
report under the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as amended, or the Exchange&nbsp;Act, as a non-U.S.&nbsp;company with
foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as we continue to qualify as a
foreign private issuer under the Exchange&nbsp;Act, we will be exempt from certain provisions of the Exchange&nbsp;Act that are applicable
to U.S.&nbsp;domestic public companies, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sections of the Exchange&nbsp;Act regulating the solicitation of proxies, consents or authorizations
                                            with respect to a security registered under the Exchange&nbsp;Act;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sections of the Exchange&nbsp;Act requiring insiders to file public reports of their share
                                            ownership and trading activities and liability for insiders who profit from trades made in
                                            a short period of time; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            rules under the Exchange&nbsp;Act requiring the filing with the SEC of quarterly reports
                                            on Form&nbsp;10-Q containing unaudited financial statements and other specified information,
                                            and current reports on Form&nbsp;8-K upon the occurrence of specified significant events.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to file an annual report on Form&nbsp;20-F within four&nbsp;months of the end of each fiscal year. However, the information
we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with
the SEC by U.S.&nbsp;domestic issuers. As a result, you may not be afforded the same protections or information, which would be made
available to you, were you investing in a U.S.&nbsp;domestic issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are taking advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign
private issuer at such time as more than 50% of our outstanding voting securities are held by U.S.&nbsp;residents and any of the following
three circumstances applies: (i)&nbsp;the majority of our executive officers or directors are U.S.&nbsp;citizens or residents; (ii)&nbsp;more
than 50% of our assets are located in the United&nbsp;States; or (iii)&nbsp;our business is administered principally in the United&nbsp;States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
foreign private issuers and emerging growth companies are also exempt from certain more stringent executive compensation disclosure rules.
Thus, even if we no longer qualify as an emerging growth company, but remain a foreign private issuer, we will continue to be exempt
from the more stringent compensation disclosures required of companies that are neither an emerging growth company nor a foreign private
issuer.</FONT></P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
<DIV STYLE="padding: 10pt; border: Black 1.5pt solid; width: 96%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
                                            OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 39%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary Shares currently
    issued and outstanding</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; width: 1%; padding-bottom: 2.25pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 60%"> 11,162,546 Ordinary Shares, par value NIS 0.02 per share. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary Shares offered
    by the selling shareholders</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 4,636,364&nbsp;Ordinary Shares issuable upon
    the exercise of the Series&nbsp;A Warrants.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary Shares to be outstanding assuming the
    full exercise of the Series A Warrants</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> 15,798,910&nbsp;Ordinary Shares. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use of proceeds</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any proceeds from the sale of the
    Ordinary Shares by the selling shareholders. All net proceeds from the sale of the Ordinary Shares covered by this prospectus will
    go to the selling shareholders. However, we will receive cash proceeds equal to the total exercise price of the Series A Warrants
    that are exercised. We intend to use the proceeds from the exercise of the Warrants for general corporate purposes and for working
    capital purposes, as well as for potential acquisitions. See &ldquo;Use of Proceeds.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk factors</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in our Ordinary Shares involves a high degree
    of risk. You should read the &ldquo;Risk Factors&rdquo; section starting on page&nbsp;8 of this prospectus and &ldquo;Item 3.D.
    Risk Factors&rdquo; in our annual report on Form 20-F for the year ended December 31, 2023, or the 2023 Annual Report, incorporated
    by reference herein, and other information included or incorporated by reference in this prospectus for a discussion of factors to
    consider carefully before deciding to invest in the Ordinary Shares.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq Capital Market
    symbol</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;PRZO&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of the Ordinary Shares issued and outstanding as shown above is based on 11,162,546 Ordinary Shares issued and outstanding as
of the date of this prospectus. This number excludes:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
to 4,636,364&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
                                            outstanding as of such date to purchase an aggregate of 353,367&nbsp;Ordinary Shares at a
                                            weighted average exercise price of $3.16;</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: left"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 463,847
                                            Ordinary Shares issuable upon the exercise of options under our incentive option plan, at
                                            a weighted average exercised price of $1.275, none of which were vested as of such date;
                                            and </P></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 146,309&nbsp;Ordinary
                                            Shares reserved for future issuance under our incentive option plan. </P></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investment
in our securities involves a high degree of risk. You should carefully consider the risks described in our 2023 Annual Report which are
incorporated by reference herein, as well as the financial or other information included in this prospectus or incorporated by reference
in this prospectus, including our financial statements and related notes, before you decide to purchase our securities. If any of the
following risks actually occur, our business, financial condition and results of operations could be materially and adversely impacted.
In that event, the trading price of our securities would likely decline and you might lose all or part of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
sale of a substantial amount of our Ordinary Shares, including resale of the held by the selling shareholder in the public market could
adversely affect the prevailing market price of our Ordinary Shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering for resale up to 4,636,364 Ordinary Shares issuable upon the exercise the Series A Warrants. Sales of substantial amounts
of shares of our Ordinary Shares in the public market, or the perception that such sales might occur, could adversely affect the market
price of our Ordinary Shares, and the market value of our other securities. We cannot predict if and when the selling shareholder may
sell such shares in the public markets. Furthermore, in the future, we may issue additional Ordinary Shares or other equity or debt securities
convertible into Ordinary Shares. Any such issuance could result in substantial dilution to our existing shareholders and could cause
our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
headquarters, research and development and other significant operations are located in Israel, and, therefore, our results may be adversely
affected by political, economic and military instability in Israel including the recent war with Hamas and other terrorist organizations
from the Gaza Strip.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive offices and research and development facilities are located in Israel. In addition, all of our key employees, officers and
directors are residents of Israel. Accordingly, political, geopolitical, economic and military conditions in Israel may directly affect
our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and
its neighboring Arab countries, the Hamas (an Islamist terrorist militia and political group that controls the Gaza strip), the Hezbollah
(an Islamist terrorist militia and political group based in Lebanon) and other terrorist organizations active in the region. These conflicts
have involved missile strikes, hostile infiltrations and terrorism against civilian targets in various parts of Israel, which have negatively
affected business conditions in Israel. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and
its trading partners could negatively affect business conditions in Israel in general and our business in particular, and adversely affect
our product development, operations and results of operations. Ongoing and revived hostilities or other Israeli political or economic
factors, such as, an interruption of operations at the Tel Aviv airport, could prevent or delay shipments of our components or products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> In October 2023, Hamas terrorists infiltrated
Israel&rsquo;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched
extensive rocket attacks on Israeli population and industrial centers located along Israel&rsquo;s border with the Gaza Strip and in
other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians and soldiers.
Following the attack, Israel&rsquo;s security cabinet declared war against Hamas and a military campaign against these terrorist organizations
commenced in parallel to their continued rocket and terror attacks. In addition, since the commencement of these events, there have been
continued hostilities along Israel&rsquo;s northern border with Lebanon (with the Hezbollah terror organization) and southern border
(with the Houthi movement in Yemen, as described below). It is possible that hostilities with Hezbollah in Lebanon will escalate, and
that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries
will join the hostilities. In addition, Iran recently launched a direct attack on Israel involving hundreds of drones and missiles and
has threatened to continue to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a
strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and
various rebel militia groups in Syria and Iraq. Such clashes may escalate in the future into a greater regional conflict. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Israeli security cabinet&rsquo;s declaration of war against Hamas and possible hostilities with other organizations,
several hundred thousand Israeli military reservists were drafted to perform immediate military service, including two employees and
our CEO who were called up for reserve service, but have since returned to work full time and their pre-war military reserve duties.
So long as the war continues, our personnel may be called up for reserve service, whether for an extended periods or periodically for
short-term periods. Military service call ups that result in absences of personnel from us for an extended period of time may materially
and adversely affect our business, prospects, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the war broke out on October&nbsp;7, 2023, our operations have not been adversely affected by this situation, and we have not experienced
disruptions to our business operations. As such, our product and business development activities remain on track. However, the intensity
and duration of Israel&rsquo;s current war against Hamas is difficult to predict at this stage, as are such war&rsquo;s economic implications
on our business and operations and on Israel&rsquo;s economy in general. If the war extends for a long period of time or expands to other
fronts, such as Lebanon, Syria and the West Bank, our operations may be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions, could harm our
results of operations and the market price of our Ordinary Shares, and could make it more difficult for us to raise capital. Parties
with whom we do business may sometimes decline to travel to Israel during periods of heightened unrest or tension, forcing us to make
alternative arrangements when necessary, in order to meet our business partners face to face. Several countries, principally in the Middle
East, still restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business
with Israel and Israeli companies if hostilities in Israel or political instability in the region continues or increases. Similarly,
Israeli companies are limited in conducting business with entities from several countries. For instance, in 2008, the Israeli legislature
passed a law forbidding any investments in entities that transact business with Iran.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle
East. Although the Israeli government has in the past covered the reinstatement value of certain damages that were caused by terrorist
attacks or acts of war, we cannot assure you that this government coverage will be maintained or, if maintained, will be sufficient to
compensate us fully for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
political conditions within Israel may affect our operations. Israel has held five general elections between 2019 and 2022, and prior
to October 2023, the Israeli government pursued extensive changes to Israel&rsquo;s judicial system, which sparked extensive political
debate and unrest. To date, these initiatives have been substantially put on hold. Actual or perceived political instability in Israel
or any negative changes in the political environment, may individually or in the aggregate adversely affect the Israeli economy and,
in turn, our business, financial condition, results of operations and growth prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to comply with the continued listing requirements of the Nasdaq Capital Market, our ordinary shares may be delisted and the price
of our ordinary shares and our ability to access the capital markets could be negatively impacted.&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Our ordinary shares are listed on the Nasdaq
Capital Market. As such, we are required to meet the continued listing requirements of the Nasdaq Capital Market and other Nasdaq rules,
including those regarding director independence and independent committee requirements, minimum shareholders&rsquo; equity, minimum share
price and certain other corporate governance requirements. In particular, we are required to maintain a minimum bid price for our listed
ordinary shares of $1.00 per share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> On February 8, 2024, we were notified in a
letter, or the Notification Letter, by the Nasdaq Listing Qualifications that we are not in compliance with the minimum bid price requirements
set forth in Nasdaq Listing Rule 5550(a)(2), or the Rule, for continued listing on The Nasdaq Capital Market. The Notification Letter
provided that we had 180 calendar days, or until August 6, 2024, to regain compliance with the Rule. To regain compliance, the bid price
of our ordinary shares must have a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. Since
we did not regain compliance by August 6, 2024, we requested and received from The Nasdaq Capital Market an additional 180 calendar days
or until February 3, 2025 to comply with the minimum bid price. If we fail to regain compliance during the second compliance period,
then Nasdaq will notify us of its determination to delist our ordinary shares, at which point we will have an opportunity to appeal the
delisting determination to a Hearings Panel. No assurance can be given that we will be able to regain compliance with the Rule. If we
do not meet these or other continued listing requirements, our ordinary shares could be delisted. Delisting of our ordinary shares from
the Nasdaq Capital Market would cause us to pursue eligibility for trading on other markets or exchanges, or on the pink sheets. In such
case, our shareholders&rsquo; ability to trade, or obtain quotations of the market value of, our ordinary shares would be severely limited
because of lower trading volumes and transaction delays. These factors could contribute to lower prices and larger spreads in the bid
and ask prices for our securities. There can be no assurance that our ordinary shares, if delisted from the Nasdaq Capital Market in
the future, would be listed on a national securities exchange, a national quotation service, the Over-The-Counter Markets or the pink
sheets. Delisting from the Nasdaq Capital Market, or even the issuance of a notice of potential delisting, would also result in negative
publicity, make it more difficult for us to raise additional capital, adversely affect the market liquidity of our ordinary shares, reduce
security analysts&rsquo; coverage of us and diminish investor, supplier and employee confidence. Additionally, the threat of delisting
or a delisting of our ordinary shares from the Nasdaq Capital Market, could reduce the number of investors willing to hold or acquire
our ordinary shares, thereby further restricting our ability to obtain equity financing, and it could reduce our ability to retain, attract
and motivate our directors, officers and employees. In addition, as a consequence of any such delisting, our share price could be negatively
affected and our shareholders would likely find it more difficult to sell, or to obtain accurate quotations as to the prices of, our
ordinary shares. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and elsewhere, including in our 2023 Annual Report incorporated by reference herein, and other information included or incorporated
by reference in this prospectus, contains forward-looking statements concerning our business, operations and financial performance and
condition, as well as our plans, objectives and expectations for our business operations and financial performance and condition. Any
statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases,
you can identify forward-looking statements by terminology such as &ldquo;aim,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;assume,&rdquo;
&ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;due,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;goal,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;objective,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo;
&ldquo;potential,&rdquo; &ldquo;positioned,&rdquo; &ldquo;seek,&rdquo; &ldquo;should,&rdquo; &ldquo;target,&rdquo; &ldquo;will,&rdquo;
&ldquo;would,&rdquo; and other similar expressions that are predictions of or indicate future events and future trends, or the negative
of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            lack of operating history;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            current and future capital requirements and our belief that our existing cash will be sufficient
                                            to fund our operations for more than one year from the date that the financial statements
                                            are issued;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain necessary regulatory approvals from the U.S.&nbsp;Federal Aviation Administration
                                            or other governmental agencies, or limitations put on the use of small unmanned aerial systems
                                            (&ldquo;UASs&rdquo;) in response to public privacy concerns;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to manufacture, market and sell our products and to generate revenues;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain our relationships with key partners and grow relationships with new partners;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain or protect the validity of our U.S.&nbsp;and other patents and other
                                            intellectual property;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to launch and penetrate markets in new locations and new market segments;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to retain key executive members and hire additional personnel;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain and expand intellectual property rights;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interpretations
                                            of current laws and the passages of future laws;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to achieve greater regulatory compliance needed in existing and new markets;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            overall demand for drone safety systems;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to achieve key performance milestones in our planned operational testing;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to establish adequate sales, marketing and distribution channels;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
                                            of our business model by investors.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain the listing of our ordinary shares on The Nasdaq Capital Market;</FONT> </TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            resurgence of the COVID-19 pandemic and its impact on our business and industry;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
                                            as to the impact of the political and security situation in Israel on our business, including
                                            due to the current war between Israel and Hamas; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                            factors referred to in our 2023 Annual Report incorporated by reference herein, as well as
                                            in our 2023 Annual Report generally, which is incorporated by reference into this prospectus.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are based on our management&rsquo;s current expectations, estimates, forecasts and projections about our business and the
industry in which we operate and our management&rsquo;s beliefs and assumptions, and are not guarantees of future performance or development
and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all
of our forward-looking statements in this prospectus may turn out to be inaccurate. Important factors that may cause actual results to
differ materially from current expectations include, among other things, those listed under &ldquo;Risk Factors&rdquo; and elsewhere
in this prospectus. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance
and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we
assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in
the future. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC
after the date of this prospectus. See &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_005"></A><B>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any proceeds from the sale of the Ordinary Shares by the selling shareholders. All net proceeds from the sale of the
Ordinary Shares will go to the selling shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may receive proceeds from the exercise of the Series A Warrants to the extent that the Series A Warrant are exercised for cash. The Series
A Warrants may, however, be exercisable on a cashless basis under certain circumstances. If the entire Series A Warrants were exercised
for cash in full, the proceeds would be approximately $5.1&nbsp;million. We intend to use the net proceeds of such warrant exercise,
if any, for general corporate purposes and for working capital purposes, as well as for potential acquisitions. We can make no assurances
that any of the Series A Warrants will be exercised, or if exercised, that it will be exercised for cash, the quantity which will be
exercised or in the period in which it will be exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The following table sets forth our total capitalization
as of June 30, 2024 on an actual basis. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this table should be read in conjunction with and is qualified by reference to the financial statements and notes thereto
and other financial information incorporated by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> As of<BR> June 30,<BR>
    2024 </TD><TD STYLE="font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-style: italic; border-bottom: Black 1.5pt solid"> U.S.&nbsp;dollars </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Actual </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; text-indent: -10pt; padding-left: 10pt"> Cash and cash equivalents </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 5,289,105 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"> Total assets </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 7,137,308 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Total non-current liabilities </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1,787,195 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"> Total shareholders&rsquo; equity </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 4,105,398 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"> Total capitalization </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 5,892,593 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The number of the ordinary shares to be issued
and outstanding immediately after this offering as shown above assumes that all of the Ordinary Shares offered hereby are sold, and is
based on 11,162,546 Ordinary Shares issued and outstanding as of June 30, 2024. This number excludes: </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
                                            to 4,636,364&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> Warrants outstanding as of such date to purchase an aggregate
of 353,367&nbsp;Ordinary Shares at a weighted average exercise price of $3.16; </TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: left"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 463,847
                                            Ordinary Shares issuable upon the exercise of options under our incentive option plan, at
                                            a weighted average exercised price of $1.275, none of which were vested as of such date;
                                            and </P></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 146,309&nbsp;Ordinary
                                            Shares reserved for future issuance under our incentive option plan. </P></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>SELLING SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The selling shareholders acquired the Series A
Warrants pursuant to a contractual agreement, as detailed in Prospectus Summary&nbsp;&mdash;&nbsp;Recent Financings&nbsp;&mdash;&nbsp;October&nbsp;2023
Private Placement&rdquo; above. We have agreed to file this registration statement covering the resale of the Ordinary Shares issuable
upon the exercise of the Series A Warrants in order to permit the selling shareholders to offer the Ordinary Shares for resale from time
to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Other than the relationships described herein,
to our knowledge, none of the selling shareholders are an employee or supplier of ours or our affiliates. Within the past three&nbsp;years,
other than the relationships described herein, none of the selling shareholders have held a position as an officer or a director of ours,
nor has the selling shareholders had any material relationship of any kind with us or any of our affiliates. All information with respect
to share ownership has been furnished by the selling shareholders, unless otherwise noted. The Ordinary Shares being offered are being
registered to permit public secondary trading of such Ordinary Shares and the selling shareholders may offer all or part of the Ordinary
Shares it owns for resale from time to time pursuant to this prospectus. The selling shareholders do not have any family relationships
with our officers, other directors or controlling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The term &ldquo;selling shareholders&rdquo; also
includes any transferees, pledgees, donees, or other successors in interest to the selling shareholders named in the table below. Unless
otherwise indicated, to our knowledge, the person named in the table below has sole voting and investment power (subject to applicable
community property laws) with respect to the Ordinary Shares set forth opposite such person&rsquo;s name. We will file a supplement to
this prospectus (or a post-effective amendment hereto, if necessary) to name successors to the named selling shareholders who are able
to use this prospectus to resell the Ordinary Shares registered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The table below lists the selling shareholders
and other information regarding the beneficial ownership of the Ordinary Shares held by the selling shareholders. The second column lists
the number of Ordinary Shares beneficially owned by each of the selling shareholders, based on its ownership of Ordinary Shares issuable
upon the exercise of the Series A Warrants, as of August 30, 2024, assuming exercise of such warrants held by the selling shareholders on
that date, without regard to any limitations on exercises. <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The third column lists the Ordinary Shares being
offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In accordance with the terms of a registration
rights agreement with the holders of the Ordinary Shares, this prospectus generally covers the resale of at least a number of Ordinary
Shares issuable upon the exercise of the Series A Warrants held by the selling shareholders. Because the number of Ordinary Shares may
be adjusted, the number of Ordinary Shares that will actually be issued may be more or less than the number of Ordinary Shares being
offered by this prospectus. The fourth column assumes the sale of all of the Ordinary Shares offered by the selling shareholders pursuant
to this prospectus. The selling shareholders may sell all, some or none of its shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Shareholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary <BR> Shares <BR> Beneficially <BR> Owned <BR> Prior to <BR> Offering<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum <BR> Number of <BR> Ordinary <BR> Shares to <BR> be Sold <BR> Pursuant to <BR> this <BR> Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ordinary <BR> Shares <BR> Owned <BR> Immediately <BR> After Sale of <BR> Maximum <BR> Number of <BR> Shares in this <BR> Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Empery Asset Master, Ltd.<SUP>(2)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,432,122</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,432,122</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Empery Tax Efficient, LP<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">769,402</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">769,402</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Empery Tax Efficient&nbsp;III, LP<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">980,294</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">980,294</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert J. Eide Pension Plan<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">280,945</TD><TD STYLE="padding-bottom: 5pt; text-align: left"><SUP>(6)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">272,728</TD><TD STYLE="padding-bottom: 5pt; text-align: left"><SUP>(7)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,217</TD><TD STYLE="padding-bottom: 5pt; text-align: left"><SUP>(8)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.I.A. Pure Capital Ltd.<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,818</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,818</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Beneficial
                                            ownership is determined in accordance with SEC rules and generally includes voting or investment
                                            power with respect to securities. Ordinary Shares subject to warrants currently exercisable,
                                            or exercisable within 60&nbsp;days of August&nbsp;30, 2024 are counted as outstanding for computing
                                            the percentage of each of the selling shareholders holding such options or warrants but are
                                            not counted as outstanding for computing the percentage of any other selling shareholders.</FONT> </TD>
</TR></TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 2,432,122&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants issued in the October&nbsp;2023 Private Placement. The foregoing warrants have a beneficial ownership limitation which prevents the holder from exceeding beneficial ownership beyond 4.99%. Accordingly, none of the warrants may be exercise at this time and are not listed as beneficially owned by the selling shareholder. Empery Asset Management LP, the authorized agent of Empery Asset Master Ltd (&ldquo;EAM&rdquo;), has discretionary authority to vote and dispose of the shares held by EAM and may be deemed to be the beneficial owner of these shares. Martin Hoe and Ryan Lane, in their capacity as investment managers of Empery Asset Management LP, may also be deemed to have investment discretion and voting power over the shares held by EAM.&nbsp;EAM, Mr.&nbsp;Hoe and Mr.&nbsp;Lane each disclaim any beneficial ownership of these shares. The address of EAM is c/o Empery Asset Management, LP, One Rockefeller Plaza, Suite 1205, New&nbsp;York, NY&nbsp;10020.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consist of 769,402&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants issued in the October&nbsp;2023 Private Placement. The foregoing warrants have a beneficial ownership limitation which prevents the holder from exceeding beneficial ownership beyond 4.99%. Accordingly, none of the warrants may be exercise at this time and are not listed as beneficially owned by the selling shareholder. Empery Asset Management LP, the authorized agent of Empery Tax Efficient, LP (&ldquo;ETE&rdquo;), has discretionary authority to vote and dispose of the shares held by ETE and may be deemed to be the beneficial owner of these shares. Martin Hoe and Ryan Lane, in their capacity as investment managers of Empery Asset Management LP, may also be deemed to have investment discretion and voting power over the shares held by ETE.&nbsp;ETE, Mr.&nbsp;Hoe and Mr.&nbsp;Lane each disclaim any beneficial ownership of these shares. The address of ETE is c/o Empery Asset Management, LP, One Rockefeller Plaza, Suite 1205, New&nbsp;York, NY&nbsp;10020.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of &nbsp;980,294&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants issued in the October&nbsp;2023 Private Placement. The foregoing warrants have a beneficial ownership limitation which prevents the holder from exceeding beneficial ownership beyond 4.99%. Accordingly, none of the warrants may be exercise at this time and are not listed as beneficially owned by the selling shareholder. Empery Asset Management LP, the authorized agent of Empery Tax Efficient&nbsp;III, LP (&ldquo;ETE&nbsp;III&rdquo;), has discretionary authority to vote and dispose of the shares held by ETE&nbsp;III and may be deemed to be the beneficial owner of these shares. Martin Hoe and Ryan Lane, in their capacity as investment managers of Empery Asset Management LP, may also be deemed to have investment discretion and voting power over the shares held by ETE&nbsp;III.&nbsp;ETE&nbsp;III, Mr.&nbsp;Hoe and Mr.&nbsp;Lane each disclaim any beneficial ownership of these shares. The address of ETE&nbsp;III is c/o Empery Asset Management, LP, One Rockefeller Plaza, Suite 1205, New&nbsp;York, NY&nbsp;10020.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert J. Eide Pension Plan&rsquo;s contact address is c/o Aegis Capital Corp., One Broadcast Plaza, Suite 300, Merrick, New York 11566. Robert Eide is a natural control person of Robert J. Eide Pension Plan. Robert Eide is the Chief Executive Officer and the indirect shareholder of 100% of the shares of Aegis Capital Corp., the placement agent of the October&nbsp;2023 Private Placement and the underwriter for the Company&rsquo;s initial public offering closed on July&nbsp;31, 2023.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of (i) 8,217 Ordinary Shares and (ii) 272,728&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants issued in the October&nbsp;2023 Private Placement. The foregoing warrants have a beneficial ownership limitation which prevents the holder from exceeding beneficial ownership beyond 9.99%.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 272,728&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants issued in the October&nbsp;2023 Private Placement. The foregoing warrants have a beneficial ownership limitation which prevents the holder from exceeding beneficial ownership beyond 9.99%.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 8,217 Ordinary Shares</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 181,818&nbsp;Ordinary Shares issuable upon the exercise of the Series&nbsp;A Warrants issued in the October&nbsp;2023 Private Placement. The foregoing warrants have a beneficial ownership limitation which prevents the holder from exceeding beneficial ownership beyond 9.99%. The address of L.I.A.&nbsp;Pure Capital Ltd., or Pure, is 20 Raoul Wallenberg St, Tel-Aviv, Israel.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_008"></A><B>DESCRIPTION OF SHARE CAPITAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The following descriptions of our share capital
and provisions of our amended and restated articles of association as in effect on the date of this prospectus are summaries and do not
purport to be complete. A form of our amended and restated articles of association was filed with the SEC as an exhibit to our registration
statement, of which this prospectus forms&nbsp;a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.25in"> As
                                            of August 30, 2024, our authorized share capital consists of NIS 4,000,000 divided into 200,000,000
                                            Ordinary Shares, par value NIS 0.02 per share, of which 11,162,546 Ordinary Shares are issued
                                            and outstanding as of such date. All of our outstanding Ordinary Shares have been validly
                                            issued, fully paid and non-assessable. Our Ordinary Shares are not redeemable and are not
                                            subject to any preemptive right. All Ordinary Shares have identical voting and other rights
                                            in all respects. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"> In addition to Ordinary
Shares, as of August 30, 2024, we have outstanding warrants to purchase an aggregate of 4,989,731
Ordinary Shares. The exercise prices of the warrants range from $1.10 to $5.00 per Ordinary Share. In addition, we have outstanding options
to purchase an aggregate of 463,847 Ordinary Shares under our incentive option plan. The exercise price of the options is $1.275 per
Ordinary Share </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Registration Number of the Company</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> Our registration number with the Israeli Registrar
of Companies is 514932821. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Purposes and Objects of the Company</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> Our purpose and objectives are set forth in
Section 3 of our amended and restated articles of association. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The Powers of the Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> Our board of directors shall direct our policy
and shall supervise the performance of our chief executive officer and his actions. Our board of directors may exercise all powers that
are not required under the Israeli Companies Law 5759-1999, or the Companies Law, or under our amended and restated articles of association
to be exercised or taken by&nbsp;<FONT STYLE="background-color: white">our shareholders</FONT>. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our Ordinary Shares shall confer upon the holders
thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> &#9679; </TD><TD STYLE="text-align: left"> equal right to
                                            attend and to vote at all of our general meetings, whether annual or special, with each Ordinary
                                            Share entitling the holder thereof, which attend the meeting and participate at the voting,
                                            either in person, electronically or by a proxy or by a written ballot, to one vote; </TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">equal right to participate in distribution of dividends,
if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata basis;
and</TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">equal right to participate, upon our dissolution, in the
distribution of our assets legally available for distribution, on a per share pro rata basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Election of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"> Pursuant to our amended and restated articles
of association, each of our directors, other than the external directors, was assigned to one of three classes with staggered three-year
terms. At each annual general meeting of our shareholders, the election or re-election of directors following the expiration of the term
of office of the directors of that class of directors will be for a term of office that expires on the third annual general meeting following
such election or re-election, such that from the annual general meeting of 2024 and after, each year the term of office of only one class
of directors will expire. The term of such directors may terminate earlier, if they resign or cease to act as board members pursuant
to the provisions of our amended and restated articles of association or any applicable law. Pursuant to our amended and restated articles
of association, other than the external directors, for whom special election requirements apply under the Companies Law, the vote required
to appoint a director is a simple majority vote of holders of our voting shares, participating and voting at the relevant meeting. In
addition, our amended and restated articles of association allow our board of directors to appoint directors to fill vacancies and/or
as an addition to the board of directors (subject to the maximum number of directors) to serve until the next annual general meeting,
or later, until the end of the term of a director who they replaced. External directors are elected for an initial term of three years,
may be elected for additional terms of three years each under certain circumstances, and may be removed from office pursuant to the terms
of the Companies Law.&nbsp;See &ldquo;Item 6.C&mdash; Directors, Senior Management, and Employees&mdash;Board Practices&mdash;External
Directors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2023 incorporated by reference herein for additional
information. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Annual and Special Meetings</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Under the Israeli law, we are required to
hold an annual general meeting of our shareholders once every calendar year, at such time and place which shall be determined by our
board of directors, but no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual
general meeting of shareholders are referred to as special general meetings. Our board of directors may call special meetings whenever
it sees fit and upon the request of any shareholder or shareholders holding at least five percent (5%) or a higher percent of our voting
rights. Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate
and vote at general meetings are the shareholders of record on a date to be decided by the board of directors, which as a company listed
on an exchange outside Israel, may be between four and 40 days prior to the date of the meeting. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Resolutions regarding the following matters
must be passed at a general meeting of our shareholders: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
  <TD><FONT STYLE="font-size: 10pt">amendments to our amended and restated articles of association;</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> <FONT STYLE="font-size: 10pt">&nbsp;</FONT> </TD>
  <TD STYLE="width: 0.25in"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
  <TD> <FONT STYLE="font-size: 10pt">the exercise of our board of director&rsquo;s powers by a general meeting if our board of directors
  is unable to exercise its powers and the exercise of any of its powers is required for our proper management;</FONT> </TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> <FONT STYLE="font-size: 10pt">&nbsp;</FONT> </TD>
  <TD STYLE="width: 0.25in"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
  <TD> <FONT STYLE="font-size: 10pt">appointment, fees or termination of our auditors, if the shareholders have not delegated their
  authority to set the fees for our auditors to our board of directors;</FONT> </TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
  <TD><FONT STYLE="font-size: 10pt">appointment of directors, including external directors;</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
  <TD><FONT STYLE="font-size: 10pt">approval of acts and transactions requiring general meeting approval pursuant to the provisions of
  the Companies Law (mainly certain related party transactions) and any other applicable law;</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
  <TD><FONT STYLE="font-size: 10pt">increases or reductions of our authorized share capital; and</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
  <TD><FONT STYLE="font-size: 10pt">a merger (as such term is defined in the Companies Law).</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Notices</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Companies Law requires that a notice of any
annual or special shareholders meeting be provided at least 21&nbsp;days prior to the meeting, and if the agenda of the meeting includes,
among others, the appointment or removal of directors, the approval of transactions with office holders or interested or related parties
or an approval of a merger, notice must be provided at least 35&nbsp;days prior to the meeting. Notwithstanding the foregoing, under
our amended and restated articles of association notice of general meetings does not have to be delivered to shareholders, and notice
by the Company of a general meeting which is published on the Company&rsquo;s website shall be deemed to have been duly given on the
date of such publication to any registered shareholder located in the State of Israel, and notice by the Company of a general meeting
which is publicized on the SEC&rsquo;s EDGAR Database or similar publication via the internet shall be deemed to have been duly given
on the date of such publication to any registered shareholder located outside of Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Quorum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> As permitted under the Companies Law, the
quorum required for our general meetings consists of at least two shareholders present in person, by proxy, written ballot or voting
by means of electronic voting system, who hold or represent between them at least 25% of the total outstanding voting rights. If within
half an hour of the time set forth for the general meeting a quorum is not present, the general meeting shall stand adjourned the same
day of the following week, at the same hour and in the same place, or to such other date, time and place as prescribed in the notice
to the shareholders and in such adjourned meeting, if no quorum is present within half an hour of the time arranged, any number of shareholders
participating in the meeting, shall constitute a quorum. If a special general meeting was called at the request of a shareholder, and
within half an hour of an adjourned meeting a legal quorum is not present, the meeting shall be cancelled. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Adoption of Resolutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our amended and restated articles of association
provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required under the Companies Law or
our amended and restated articles of association. A shareholder may vote in a general meeting in person, by proxy or by a written ballot.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Changing Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> If at any time the share capital of the Company
is divided into different classes of shares, the rights attached to any class, unless otherwise provided by the Companies Law or our
amended and restated articles of association, may be modified or cancelled by the Company by a resolution of the General Meeting of the
holders of all shares as one class, without any required separate resolution of any class of shares. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An increase in the authorized share capital,
the creation of a new class of shares, an increase in the authorized share capital of a class of shares, or the issuance of additional
shares thereof out of the authorized and unissued share capital, shall not be deemed to modify or derogate or cancel the rights attached
to the previously issued shares of such class or of any other class, unless otherwise provided by the terms of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Provisions Restricting Change in Control of Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> There are no specific provisions of our amended
and restated articles of association that would have an effect of delaying, deferring or preventing a change in control of our company
or that would operate only with respect to a merger, acquisition or corporate restructuring involving us (or our subsidiary). However,
as described below, certain provisions of the Companies Law may have such effect. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The Companies Law includes provisions that
allow a merger transaction and requires that each company that is a party to the merger have the transaction approved by its board of
directors and, unless certain requirements described under the Companies Law are met, a vote of the majority of shareholders, and, in
the case of the target company, also a majority vote of each class of its shares. For purposes of the shareholder vote of each party,
unless a court rules otherwise, the merger will not be deemed approved if shares representing a majority of the voting power present
at the shareholders meeting and which are not held by the other party to the merger (or by any person or group of persons acting in concert
who holds 25% or more of the voting power or the right to appoint 25% or more of the directors of the other party) vote against the merger.
If, however, the merger involves a merger with a company&rsquo;s own controlling shareholder or if the controlling shareholder has a
personal interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary
transactions with controlling shareholders. Upon the request of a creditor of either party to the proposed merger, the court may delay
or prevent the merger if it concludes that there exists a reasonable concern that as a result of the merger the surviving company will
be unable to satisfy the obligations of any of the parties to the merger, and may further give instructions to secure the rights of creditors.
If the transaction would have been approved by the shareholders of a merging company but for the separate approval of each class or the
exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the petition of holders of
at least 25% of the voting rights of a company. For such petition to be granted, the court must find that the merger is fair and reasonable,
taking into account the value of the parties to the merger and the consideration offered to the shareholders. In addition, a merger may
not be completed unless at least (1) 50 days have passed from the time that the requisite proposals for approval of the merger were filed
with the Israeli Registrar of Companies by each merging company, and (2) 30 days have passed since the merger was approved by the shareholders
of each merging company. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The Companies Law also provides that, subject
to certain exceptions, an acquisition of shares in an Israeli public company must be made by means of a &ldquo;special&rdquo; tender
offer if as a result of the acquisition (1) the purchaser would become a holder of 25% or more of the voting rights in the company if
there is no holder of 25% or more of the voting rights in the company, or (2) the purchaser would become a holder of 45% or more of the
voting rights in the company, unless there is already a holder of more than 45% of the voting rights in the company. These requirements
do not apply if, in general, the acquisition (1) was made in a private placement that received shareholders&rsquo; approval, subject
to certain conditions, (2) was made from a holder of 25% or more of the voting rights in the company which resulted in the acquirer becoming
a holder of 25% or more of the voting rights in the company, or (3) was made from a holder of more than 45% of the voting rights in the
company which resulted in the acquirer becoming a holder of more than 45% of the voting rights in the company. A &ldquo;special&rdquo;
tender offer must be extended to all shareholders. In general, a &ldquo;special&rdquo; tender offer may be consummated only if (1) at
least 5% of the voting power attached to the company&rsquo;s outstanding shares will be acquired by the offeror, and (2) the offer is
accepted by a majority of the offerees who notified the company of their position in connection with such offer (excluding the controlling
shareholder of the offeror, holder of 25% or more of the voting rights in the company or anyone on their behalf or on behalf of the offeror,
including their relatives or corporations under their control or any person having a personal interest in the acceptance of the tender
offer). If a special tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with
the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase of shares of the target company
and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or
such person or entity undertook to effect such an offer or merger in the initial special tender offer. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If, as a result of an acquisition of shares,
the acquirer will hold more than 90% of an Israeli company&rsquo;s outstanding shares or of certain class of shares, the acquisition
must be made by means of a tender offer for all of the outstanding shares, or for all of the outstanding shares of such class, as applicable.
In general, if less than 5% of the outstanding shares, or of applicable class, are not tendered in the tender offer and more than half
of the offerees who have no personal interest in the offer tendered their shares, all the shares that the acquirer offered to purchase
will be transferred to it by operation of law. However, a tender offer will also be accepted if the shareholders who do not accept the
offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares. Any shareholders
that was an offeree in such tender offer, whether such shareholder accepted the tender offer or not, may request, by petition to an Israeli
court, (i)&nbsp;appraisal rights in connection with a full tender offer, and (ii)&nbsp;that the fair value should be paid as determined
by the court, for a period of six&nbsp;months following the acceptance thereof. However, the acquirer is entitled to stipulate, under
certain conditions, that tendering shareholders will forfeit such appraisal rights. If the full tender offer was not accepted in accordance
with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its holdings to more than 90%
of the company&rsquo;s voting rights or the company&rsquo;s issued and outstanding share capital (or of the applicable class) from shareholders
who accepted the tender offer. Shares purchased in contradiction to the full tender offer rules under the Companies Law will have no
rights and will become dormant shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Lastly, Israeli tax law treats some acquisitions,
such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably than U.S. tax laws. For example, Israeli
tax law may, under certain circumstances, subject a shareholder who exchanges his ordinary shares for shares in another corporation to
taxation prior to the sale of the shares received in such stock-for-stock swap. With respect to mergers, Israeli tax law allows for tax
deferral in certain circumstances but makes the deferral contingent on the fulfilment of numerous conditions, including a holding period
of two years from the date of the transaction during which certain sales and dispositions of shares of the participating companies are
restricted. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Exclusive Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Our amended and restated articles of association
provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States
shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Section
22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly,
both U.S. state and federal courts have jurisdiction to entertain such claims. This choice of forum provision may limit a shareholder&rsquo;s
ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees
and may increase the costs associated with such lawsuits, which may discourage such lawsuits against us and our directors, officers and
employees. Further, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions, suits,
or proceedings asserting a cause of action arising under the Securities Act) in other companies&rsquo; organizational documents and similar
agreements has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum
provision in our amended and restated articles of association. If a court were to find these provisions of our amended and restated articles
of association are inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we
may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and
financial condition. Any person or entity purchasing or otherwise acquiring any interest in our share capital shall be deemed to have
notice of and to have consented to the choice of forum provisions of our amended and restated articles of association are described above.
This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which
the U.S. federal courts have exclusive jurisdiction. Our amended and restated articles of association also provide that unless we consent
in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel, shall be the exclusive forum for any derivative
action or proceeding brought on behalf of our company, any action asserting a breach of a fiduciary duty owed by any of our directors,
officers or other employees to our company or our shareholders or any action asserting a claim arising pursuant to any provision of the
Companies Law or the Israeli Securities Law,&nbsp;5728-1968. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Changes in Our Capital</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The general meeting may, by a simple majority
vote of the shareholders attending the general meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left; width: 0.25in">&#9679;</TD>
  <TD>increase our registered share capital by the creation of new shares from the existing class or a new class, as determined by the
  general meeting;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&#9679;</TD>
  <TD>cancel any registered share capital which have not been taken or agreed to be taken by any person;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&#9679;</TD>
  <TD>consolidate and divide all or any of our share capital into shares of larger nominal value than our existing shares;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&#9679;</TD>
  <TD>subdivide our existing shares or any of them, our share capital or any of it, into shares of smaller nominal value than is fixed;
  and</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: left">&#9679;</TD>
  <TD>reduce our share capital and any fund reserved for capital redemption in any manner, and with and subject to any incident authorized,
  and consent required, by the Companies Law.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_009"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are registering the ordinary shares previously
issued and upon exercise of the warrants to permit the resale of these ordinary shares by the holders thereof and holders of the ordinary
shares warrants from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling
shareholders of the ordinary shares. We will bear all fees and expenses incident to our obligation to register the ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The selling shareholders may sell all or a portion
of the ordinary shares beneficially owned by them and offered hereby from time to time directly or through one or more underwriters,
broker-dealers or agents. If the ordinary shares are sold through underwriters or broker-dealers, the selling shareholders will be responsible
for underwriting discounts or commissions or agent&rsquo;s commissions. The ordinary shares may be sold in one or more transactions at
fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated
prices. These sales may be effected in transactions, which may involve crosses or block transactions,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">&#9679;</TD>
  <TD>on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>in the over-the-counter market;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>in transactions otherwise than on these exchanges or systems or in the over-the-counter market;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>through the writing of options, whether such options are listed on an options exchange or otherwise;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block
  as principal to facilitate the transaction;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>privately negotiated transactions;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>short sales;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>sales pursuant to Rule&nbsp;144;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>a combination of any such methods of sale; and</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>any other method permitted pursuant to applicable law.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the selling shareholders effect such transactions
by selling ordinary shares to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive
commissions in the form of discounts, concessions or commissions from the selling shareholders or commissions from purchasers of the
ordinary shares for whom they may act as agent or to whom they may sell as principal (which discounts, concessions or commissions as
to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection
with sales of the ordinary shares or otherwise, the selling shareholders may enter into hedging transactions with broker-dealers, which
may in turn engage in short sales of the ordinary shares in the course of hedging in positions they assume. The selling shareholders
may also sell ordinary shares short and ordinary shares covered by this prospectus to close out short positions and to return borrowed
shares in connection with such short sales. The selling shareholders may also loan or pledge ordinary shares to broker-dealers that in
turn may sell such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The selling shareholders may pledge or grant
a security interest in some or all of the warrants or ordinary shares owned by them and, if they default in the performance of their
secured obligations, the pledgees or secured parties may offer and sell the ordinary shares from time to time pursuant to this prospectus
or any amendment to this prospectus under Rule&nbsp;424(b)(3)&nbsp;or other applicable provision of the Securities Act&nbsp;of&nbsp;1933,
as amended, amending, if necessary, the list of selling shareholders to include the pledgee, transferee or other successors in interest
as selling shareholders under this prospectus. The selling shareholders also may transfer and donate the ordinary shares in other circumstances
in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The selling shareholders and any broker-dealer
participating in the distribution of the ordinary shares may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities
Act, and any commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions
or discounts under the Securities Act. At the time a particular offering of the ordinary shares is made, a prospectus supplement, if
required, will be distributed which will set forth the aggregate amount of ordinary shares being offered and the terms of the offering,
including the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation from
the selling shareholders and any discounts, commissions or concessions allowed or reallowed or paid to broker-dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the securities laws of some states, the
ordinary shares may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the ordinary
shares may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration
or qualification is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There can be no assurance that any selling shareholders
will sell any or all of the ordinary shares registered pursuant to the registration statement, of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The selling shareholders and any other person
participating in such distribution will be subject to applicable provisions of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as
amended, and the rules and regulations thereunder, including, without limitation, Regulation&nbsp;M of the Exchange&nbsp;Act, which may
limit the timing of purchases and sales of any of the ordinary shares by the selling shareholders and any other participating person.
Regulation&nbsp;M may also restrict the ability of any person engaged in the distribution of the ordinary shares to engage in market-making
activities with respect to the ordinary shares. All of the foregoing may affect the marketability of the ordinary shares and the ability
of any person or entity to engage in market-making activities with respect to the ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will pay all expenses of the registration
of the ordinary shares pursuant to the registration rights agreement, estimated to be $100,000 in total, including, without limitation,
Securities and Exchange Commission filing fees and expenses of compliance with state securities or &ldquo;blue sky&rdquo; laws; provided,
however, that a selling shareholder will pay all underwriting discounts and selling commissions, if any. We will indemnify the selling
shareholders against liabilities, including some liabilities under the Securities Act, in accordance with the registration rights agreements,
or the selling shareholders will be entitled to contribution. We may be indemnified by the selling shareholders against civil liabilities,
including liabilities under the Securities Act, that may arise from any written information furnished to us by the selling shareholders
specifically for use in this prospectus, in accordance with the related registration rights agreement, or we may be entitled to contribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once sold under the registration statement, of
which this prospectus forms a part, the ordinary shares will be freely tradable in the hands of persons other than our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The validity of the issuance of our securities
offered in this prospectus and certain other matters of Israeli law will be passed upon for us by Gornitzky&nbsp;&amp; Co. Certain other
matters of U.S.&nbsp;federal law and New&nbsp;York state law will be passed upon for us by Greenberg Traurig, P.A., Tel Aviv, Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt; background-color: white">The
consolidated financial statements as of and for the year ended December&nbsp;31, 2023 of ParaZero Technologies Ltd. incorporated by reference
in this prospectus and elsewhere in the registration statement, have been so incorporated by reference in reliance upon the report of
<FONT STYLE="font-family: Times New Roman, Times, Serif">Brightman Almagor Zohar&nbsp;&amp; Co.</FONT>, an independent registered public
accounting firm, upon the authority of such firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_012"></A><B>ENFORCEMENT OF CIVIL LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are incorporated under the laws of the State
of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in this registration statement,
most of whom reside outside of the United&nbsp;States, may be difficult to obtain within the United&nbsp;States. Furthermore, because
substantially all of our assets and substantially all of our directors and officers are located outside of the United&nbsp;States, any
judgment obtained in the United&nbsp;States against us or any of our directors and officers may not be collectible within the United&nbsp;States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have been informed by our legal counsel in
Israel, Gornitzky&nbsp;&amp; Co., that it may be difficult to assert U.S.&nbsp;securities law claims in original actions instituted in
Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S.&nbsp;securities laws reasoning that Israel is
not the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine
that Israeli law and not U.S.&nbsp;law is applicable to the claim. If U.S.&nbsp;law is found to be applicable, the content of applicable
U.S.&nbsp;law must be proved as a fact which can be a time-consuming and costly process. Certain matters of procedure will also be governed
by Israeli law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have irrevocably appointed Puglisi&nbsp;&amp;
Associates as our agent to receive service of process in any action against us in any U.S.&nbsp;federal or state court arising out of
this offering or any purchase or sale of securities in connection with this offering. Subject to specified time limitations and legal
procedures, Israeli courts may enforce a U.S.&nbsp;judgment in a civil matter which, subject to certain exceptions, is non-appealable,
including a judgment based upon the civil liability provisions of the Securities Act and the Exchange&nbsp;Act and including a monetary
or compensatory judgment in a non-civil matter, provided that among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">&#9679;</TD>
  <TD>the judgment was rendered by a court which was, according to the laws of the state of the court, competent to render the judgment;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>the obligation imposed by the judgment is enforceable according to the rules relating to the enforceability of judgments in Israel
  and the substance of the judgment is not contrary to public policy; and</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>the judgment is executory in the state in which it was given.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Even if these conditions are met, an Israeli
court may not declare a foreign civil judgment enforceable if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">&#9679;</TD>
  <TD>the judgment was not obtained after due process before a court of competent jurisdiction, according to the laws of the state in
  which the judgment was given and the rules of private international law currently prevailing in Israel;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>the prevailing law of the foreign state in which the judgment was rendered does not allow for the enforcement of judgments of Israeli
  courts;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>adequate service of process has not been effected and the defendant has not had a reasonable opportunity to be heard and to present
  his or her evidence;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>the judgment is contrary to public policy of Israel, or the enforcement of the civil liabilities set forth in the judgment is likely
  to impair the security or sovereignty of Israel;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>the judgment was obtained by fraud or conflicts with any other valid judgments in the same matter between the same parties; and</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>an action between the same parties in the same matter is pending in any Israeli court at the time the lawsuit is instituted in
  the foreign court.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If a foreign judgment is enforced by an Israeli
court, it generally will be payable in Israeli shekel, which can then be converted into non-Israeli currency and transferred out of Israel.
The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue
a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the judgment, but the judgment
debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency
ordinarily will be linked to the Israeli consumer price index plus interest at the annual statutory rate set by Israeli regulations prevailing
at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> We
                                            have filed with the SEC a registration statement on Form&nbsp;F-3 under the Securities Act
                                            relating to this offering of our securities. This prospectus does not contain all of the
                                            information contained in the registration statement. The rules and regulations of the SEC
                                            allow us to omit certain information from this prospectus that is included in the registration
                                            statement. Statements made in this prospectus concerning the contents of any contract, agreement
                                            or other document are summaries of all material information about the documents summarized,
                                            but are not complete descriptions of all terms of these documents. If we filed any of these
                                            documents as an exhibit to the registration statement, you may read the document itself for
                                            a complete description of its terms. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our SEC filings are available to the public at
the SEC&rsquo;s website at&nbsp;<I>http://www.sec.gov</I>. Upon completion of this offering, we will be subject to the information reporting
requirements of the Exchange&nbsp;Act that are applicable to foreign private issuers, and under those requirements will file reports
with the SEC.&nbsp;As a foreign private issuer, we will be exempt from the rules under the Exchange&nbsp;Act related to the furnishing
and content of proxy statements, and our officers, directors and principal shareholders will be exempt from the reporting and short-swing
profit recovery provisions contained in Section&nbsp;16 of the Exchange&nbsp;Act. In addition, we will not be required under the Exchange&nbsp;Act
to file reports and financial statements with the SEC as frequently or as promptly as U.S.&nbsp;companies whose securities are registered
under the Exchange&nbsp;Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We maintain a corporate website at&nbsp;<I>www.parazero.com</I>.
Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><A NAME="a_014"></A><B>INCORPORATION OF CERTAIN
INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The SEC allows us to incorporate
by reference information into this document. This means that we can disclose important information to you by referring you to another
document filed separately with the SEC. The information incorporated by reference is considered to be a part of this document, except
for any information superseded by information that is included directly in this prospectus or incorporated by reference subsequent to
the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We incorporate by reference the following documents
or information that we have filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1916241/000121390024024822/ea0201876-20f_parazero.htm">Form
                                                                                                                                                             20-F</A> for the fiscal year ended December 31, 2023, filed with the SEC on March 21, 2024; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.15pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Reports of Foreign
    Private Issuer on Form 6-K filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024024929/ea0202334-6k_parazero.htm">March
    22, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024035793/ea0204566-6k_parazero.htm">April 24,
    2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024036215/ea0204647-6k_parazero.htm">April 25, 2024</A>,
    May 21, 2024, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024047227/ea0206934-6k_parazero.htm">May 29,
    2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024058967/ea0208941-6k_parazero.htm">July 3, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024060654/ea0209203-6k_parazero.htm">July
    11, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000101376224000736/ea0209941-6k_parazero.htm">July 24,
    2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024066808/ea0210927-6k_parazero.htm">August 9, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024067650/ea0211115-6k_para.htm">August
    12, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024073102/ea0212577-6k_parazero.htm">August 28, 2024</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1916241/000121390024075069/ea0213160-6k_parazerotech.htm" STYLE="-sec-extract: exhibit">September 3, 2024</A> (to the extent expressly incorporated by reference into our effective
    registration statements filed by us under the Securities Act); and</FONT> </TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.15pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>the description of our ordinary shares contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1916241/000121390024024822/ea020187601ex2-1_parazero.htm">Exhibit 2.1</A> to
our Annual Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on March 21, 2024, including any amendment or
report filed with the SEC for the purpose of updating such description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> All subsequent annual reports filed by us
pursuant to the Exchange Act on Form 20-F prior to the termination of an offering shall be deemed to be incorporated by reference to
this prospectus and to be a part hereof from the date of filing of such documents. We may also incorporate part or all of any Form 6-K
subsequently submitted by us to the SEC prior to the termination of an offering by identifying in such Forms 6-K that they, or certain
parts of their contents, are being incorporated by reference herein, and any Forms 6-K so identified shall be deemed to be incorporated
by reference in this prospectus and to be a part hereof from the date of submission of such documents. Any statement contained in a document
incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The information we incorporate by reference
is an important part of this prospectus, and later information that we file with the SEC will automatically update and supersede the
information contained in this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> We
                                            will provide you without charge, upon your written or oral request, a copy of any of the
                                            documents incorporated by reference in this prospectus, other than exhibits to such documents
                                            which are not specifically incorporated by reference into such documents. Please direct your
                                            written or telephone requests to us at ParaZero Technologies Ltd., 1 HaTachana St., Kfar
                                            Saba, Israel 4453001, Attention: Yuval Tovias, Chief Financial Officer, telephone number:&nbsp;+972-50-275-3666. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 8. Indemnification of Directors, Officers
and Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Indemnification</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Israeli Companies Law,&nbsp;5759-1999, or
the Companies Law, and the Israeli Securities Law,&nbsp;5728-1968, or the Securities Law, provide that a company may indemnify an office
holder against the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant
to an undertaking made in advance of an event or following an event, provided its articles of association include a provision authorizing
such indemnification:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">&#9679;</TD>
  <TD>a financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her
  capacity as an office holder, including a settlement or arbitrator&rsquo;s award approved by a court. However, if an undertaking to
  indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events
  which, in the opinion of the board of directors, can be foreseen based on the company&rsquo;s activities when the undertaking to indemnify
  is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and
  such undertaking shall detail the abovementioned events and amount or criteria;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>reasonable litigation expenses, including attorneys&rsquo; fees, expended by the office holder (a)&nbsp;as a result of an investigation
  or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1)&nbsp;no
  indictment (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding;
  and (2)&nbsp;no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon
  him or her as a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect
  to an offense that does not require proof of criminal intent; or (b)&nbsp;in connection with a monetary sanction;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD>&#9679;</TD>
  <TD>reasonable litigation expenses, including attorneys&rsquo; fees, expended by the office holder or imposed on him or her by a court
  (1)&nbsp;in proceedings that the company institutes, or that another person institutes on the company&rsquo;s behalf, against him or
  her; (2)&nbsp;in a criminal proceeding of which he or she was acquitted; or (3)&nbsp;as a result of a conviction for a crime that does
  not require proof of criminal intent; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Securities Law, an Israeli Company
may also indemnify an office holder for expenses incurred by an office holder in connection with an Administrative Procedure under the
Securities Law, including reasonable litigation expenses and reasonable attorneys&rsquo; fees. An &ldquo;Administrative Procedure&rdquo;
is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement
Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject
to conditions) to the Securities Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We entered into indemnification agreements with
all of our directors and with all members of our senior management immediately prior to the closing of this offering. Each such indemnification
agreement will provide each office holder with indemnification permitted under applicable law and up to a certain amount, and to the
extent that these liabilities are not covered by directors&rsquo; and officers&rsquo; insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Exculpation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the Companies Law, an Israeli company may
not exculpate an office holder from liability for a breach of his or her duty of loyalty, but may exculpate in advance an office holder
from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach of his or her
duty of care (other than in relation to distributions), but only if a provision authorizing such exculpation is included in its articles
of association. Our amended and restated articles of association provide that we may exculpate, in whole or in part, any office holder
from liability to us for damages caused to the company as a result of a breach of his or her duty of care.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to the aforesaid limitations, under the indemnification agreements,
we intend to exculpate and release our office holders from any and all liability to us related to any breach by them of their duty of
care to us to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Limitations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Companies Law provides that the Company may
not exculpate or indemnify an office holder nor enter into an insurance contract that would provide coverage for any liability incurred
as a result of any of the following: (1)&nbsp;a breach by the office holder of his or her duty of loyalty unless (in the case of indemnity
or insurance only, but not exculpation) the office holder acted in good faith and had a reasonable basis to believe that the act would
not prejudice us; (2)&nbsp;a breach by the office holder of his or her duty of care if the breach was carried out intentionally or recklessly
(as opposed to merely negligently); (3)&nbsp;any act or omission committed with the intent to derive an illegal personal benefit; or
(4)&nbsp;any fine, monetary sanction, penalty or forfeit levied against the office holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the Companies Law, exculpation, indemnification
and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with
respect to certain office holders or under certain circumstances, also by the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our amended and restated articles of association
permit us to exculpate, indemnify and insure our office holders to the fullest extent permitted or to be permitted by the Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9. Exhibits and Financial Statement Schedules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 10%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    <BR>
    NUMBER</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; width: 1%; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 89%; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    DESCRIPTION</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390024067166/ea020999701ex4-1_parazero.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Articles of Association of the Registrant (filed as Exhibit 4.1 to our Registration Statement on Form F-3 as filed with the Securities and Exchange Commission on August 9, 2024, and incorporated herein by reference).</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023083936/ff12023ex5-1_parazerotech.htm">Opinion of Gornitzky&nbsp;&amp; Co., Israeli counsel to the Registrant, as to the validity of the Ordinary Shares.</A></FONT> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023081381/ea187311ex99-1_parazero.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Placement Agent Agreement (filed as Exhibit 99.1 to Form&nbsp;6-K furnished to the Securities and Exchange Commission on October&nbsp;26,
    2023, and incorporated herein by reference).</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023081381/ea187311ex99-2_parazero.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Securities Purchase Agreement (filed as Exhibit 99.2 to Form&nbsp;6-K furnished to the Securities and Exchange Commission on October&nbsp;26,
    2023, and incorporated herein by reference).</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023081381/ea187311ex99-3_parazero.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Registration Rights Agreement (filed as Exhibit 99.3 to Form&nbsp;6-K furnished to the Securities and Exchange Commission on October&nbsp;26,
    2023, and incorporated herein by reference).</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023081381/ea187311ex99-4_parazero.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Series&nbsp;A and Series&nbsp;B Warrants (filed as Exhibit 99.4 to Form&nbsp;6-K furnished to the Securities and Exchange Commission
    on October&nbsp;26, 2023, and incorporated herein by reference).</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023081381/ea187311ex99-5_parazero.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Pre-Funded Warrant (filed as Exhibit 99.5 to Form&nbsp;6-K furnished to the Securities and Exchange Commission on October&nbsp;26,
    2023, and incorporated herein by reference).</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1**</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD><A HREF="ea021212001ex23-1_para.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Brightman Almagor Zohar &amp; Co.</FONT> </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023083936/ff12023ex5-1_parazerotech.htm">Consent of Gornitzky&nbsp;&amp; Co. (included in Exhibit 5.1).</A></FONT> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023083936/ff12023_parazerotech.htm#T6666666">Power of Attorney (included in signature pages of Registration Statement).</A></FONT> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1916241/000121390023083936/ff12023ex-fee_parazerotech.htm">Filing Fee Table.</A></FONT> </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in">*</TD>
  <TD>Previously filed.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in">**</TD>
  <TD>Filed herewith.</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 10. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The undersigned Registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To file, during any period in which offers or sales are being made, a
    post-effective amendment to this registration statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To include any prospectus required by section 10(a)(3) of the Securities
    Act of 1933;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective
    date of the registration statement (or the most recent post- effective amendment thereof) which, individually or in the aggregate,
    represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase
    or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered)
    and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed
    with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change
    in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration
    statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To include any material information with respect to the plan of distribution
    not previously disclosed in the registration statement or any material change to such information in the registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 22px">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and a(l)(iii)
    do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be included in a post-effective
    amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13
    or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained
    in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">That for the purpose of determining any liability under the Securities
    Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement
    relating to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona
    fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To remove from registration by means of a post-effective amendment any
    of the securities being registered which remain unsold at the termination of the offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To file a post-effective amendment to the registration statement to include
    any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering.
    Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant
    includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4)
    and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those
    financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment
    need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or Rule 3-19 of this chapter
    if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by the registrant
    pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">That, for the purpose of determining liability under the Securities Act
    to any purchaser:</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall
    be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration
    statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">i..</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5)
    or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i),
    (vii) or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part
    of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness
    or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for
    liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective
    date of the registration statement relating to the securities in the registration statement to which the prospectus relates, and
    the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that
    No statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated
    or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will,
    as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in
    the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior
    to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The undersigned registrant hereby undertakes that, for purposes of determining
    any liability under the Securities Act of 1933, each filing of the registrant&rsquo;s annual report pursuant to section 13(a) or section
    15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant
    to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
    deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
    time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">That for purposes of determining any liability under the Securities Act
    of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A
    and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act
    shall be deemed to be part of this registration statement as of the time it was declared effective.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities
    Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described
    in Item 6 hereof, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public
    policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
    (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant
    in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
    with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
    precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy
    as expressed in the Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Pursuant to the requirements of the Securities
Act&nbsp;of&nbsp;1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form&nbsp;F-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Kfar Saba, Israel on this 3<SUP>rd</SUP>&nbsp;day of September, 2024.&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PARAZERO TECHNOLOGIES&nbsp;LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="width: 4%; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="width: 36%; padding-bottom: 2.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Boaz Shetzer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boaz Shetzer, Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 41%; border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 17%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Boaz
    Shetzer</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boaz Shetzer</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Yuval
    Tovias</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> September 3, 2024 </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yuval Tovias</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors, Director</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> September 3, 2024 </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitay Weiss</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> September 3, 2024 </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moshe Revach</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> September 3, 2024 </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.&nbsp;Roy Borochov</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tali Dinar</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naama Falach Avrahamy</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> September 3, 2024 </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yigal Shtief</FONT> </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt">* /s/ <FONT STYLE="font-family: Times New Roman, Times, Serif">Boaz
    Shetzer</FONT></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boaz Shetzer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Attorney in Fact</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE
UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Pursuant to the requirements of the Securities
Act&nbsp;of&nbsp;1933, as amended, the undersigned, the duly authorized representative in the United&nbsp;States of ParaZero Technologies
Ltd., has signed this Registration Statement on this 3<SUP>rd</SUP> day of September, 2024. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 2.25pt">Puglisi&nbsp;&amp; Associates<BR>
 Authorized U.S.&nbsp;Representative</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 2.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Donald J.&nbsp;Puglisi</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald J.&nbsp;Puglisi</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</FONT></TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ea021212001ex23-1_para.htm
<DESCRIPTION>CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in this Registration Statement on in this Post-Effective Amendment No. 2 to the Registration
Statement on Form F-3, of our report dated March 21, 2024, relating to the financial statements of ParaZero Technologies Ltd., appearing
in the Annual Report on Form 20-F of ParaZero Technologies Ltd. for the year ended December 31, 2023. We also consent to the reference
to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>/s/
Brightman Almagor Zohar &amp; Co.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certified
Public Accountants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
Firm in the Deloitte Global Network</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
Aviv, Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
3, 2024</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q /(# 2(  A$! Q$!_\0
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M9KB;7_C!8:#+(1:Q>1"JCMYA!8_7G]* .NA^-GB/6B\WAWP)>7EHAYDRS?\
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MUI<6^FI(!<3M<3/*^YY';J2: &:_8^(+PP?V)K,&G!<^;YMJ)M_3&,D8QS7
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MB:&V/V@A@A.<$XYQ@ >U97_"@? W_/"__P# H_X4 =S_ ,)1X> _Y#NE@?\
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8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #4 3 # 2(  A$! Q$!_\0
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MWU*2:224JN]#*<L!QBJ:_"_2UL]0L?M5R+*^BB$EN@5566/&V9<#A_E!/8T
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MB&^T5-EM=QA=Q4J%8,",$$ 5)%X0@MO$%SK%K>W<$M[$L5XB,,3E1A6)QD,
M>HH K-\1="C\_P XW,/DV9O2'BP3$&V$XZ@Y[''K4>H>./*N_#\5E9/+'JMZ
M;<2%E(V!-Y92"0<\8Y[&H-.^&EGIMS'<Q:I?/.EL]KOEV,61GW_-D<G.1SU!
MJ=/AWID*V'V:::V>SOWOXS %5=[C:RA<85<=ATH [&BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **HZ
MQJ<6C:->:E.CO%:Q-*ZH,L0!GBN<L_&;7'AR]UA8[*2WC!-O.MT!%(<X"LQ'
MRGISCO0!V-%<3!XTU".'2X]0TVSCOM4NFAM([:]$T;(J[BY<+TXQ@ U1N?B%
MK%SH,6NZ'X=AN]-\@O/)<7HA*2!BIC VG<<C'OD4 >B45Y_J7Q"O-+U?4=/G
MTRV#V6E+J39NB"Y/6)1M^]D$#UXKL])U#^U=(L[_ .SRV_VF%9?)E&'3(S@C
MUH NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !12,P7J0*3>O\ >'YT .HIN]?[P_.C>O\ >'YT 17J
M326,R6WE><R$)YHRF?<>E><6/@&ZL)]8N[#3-.6&^8+)I-TQ:VD(DSO  (4[
M>!Q]:],WK_>'YT;U_O#\Z //T^'*6%UIM_I:0V[V5^]VMDK'RD5X]C(A[<@-
MZ=:MZ;X(GTSPQHN@)-');07?VF^<Y'F_,9-H'IO(_ 5VN]?[P_.C>O\ >'YT
M >>ZWX,U+5/&&M:D;6TDM;[2181"9^4<$D.1CH">W/%=?X:TRYT;PY8:;>7K
MWMQ;0B.2X?JY'^<?A6GO7^\/SHWK_>'YT .HIN]?[P_.C>O]X?G0 ZBF&11_
M$/SIXH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $P 3<# 2(  A$! Q$!_\0
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D)
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MQDFW8^1T4#*$#@C .?6@"C9^(?%'B378M&MI(=#GMM-AN[]I(/.<2R=(U4G
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MKZ<=ZRKFUBGFA33+:[+-'N>)QN8'U&!TQS757CZC;_#_ ,.BT@9F+S%@80Y
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MK>&+&(WVI:W':W5HNHNKK;W"[&7 PS;?X2QY/T%6;WP^+OQ&NJ&<>6]B]C/
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MI,VV4=!#\PZ@C^[D_7'K6GI=Q<W$4IN8!"R2LB@ @%1T/-7LBC(H **,BB@
MHHHH **** .3^)'_ "(>I?[J_P#H0KY\KZ#^)'_(AZE_NK_Z$*^?*X,3\2/K
M\A_@2]?T"BBBN8^@'1QO+((XD9W;HJC)-27%G=6A N;>6'=T\Q"N:Z>R0:;\
M.;K4K?Y;N[O!:F4?>2,#) /;-'@D?VG)J6C79,EK-:22@,<^7(HR&'H:U4-4
MNK."6*:C*:7NQ=O/I?\ ,YD65TRAA;3%3T(0X-(;2Y$@C^SR[R,A=AR1773^
M:_PXT8?V@MMMO)AN=W&X8Z#:#5.TEGM/%>D1C4/M?D;7CE#$CYN2 3SC/K3<
M$B(8N<DVDM+]^AS#*R,58%6!P01@BGF"98A*T3B,]'*G!_&NN\2Z:FM:AIFM
M6:A+?5ES.1TBE7_69].!FI?&-XMYX0\-R0KL@S,L:#@;5("_I_.DZ=K^01QO
M.Z:2^+?R_JQQ%%%%9'I!7U%I'_(&L?\ KW3_ -!%?+M?46D?\@:Q_P"N"?\
MH(KKPO4^9S_:G\R[1117:?+!1110 4444 >;71NO"SR:C \.K>%;_4 \T#?Z
MZTEDE W(?X@),?*>0>E:>G:EK6L:H+R"ZMH+6VU*6UN(9)2=T:DJ%V;>'S@@
MYZ5TB>'])CG69;" 2+(90=O <G);'3.23FG)H>EQZK)J:6,"WL@P\P7#-VY]
M_>@#S?3O^/71/^QMN?\ T*:M237=7$EQ&+[!_P"$F33PPB7(A95.WIUYZ]:[
M%/#NC1K$J:;;J(IC<1@)]V0]7'O[T?\ "/:.69O[.M\M.+DG9UE'\?\ O>]
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M5@44N=VL-86FI*2WO?YVL%%%%0=05]1:1_R!K'_K@G_H(KY=KZBTC_D#6/\
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M1]GA_P">,?\ WR*/L\/_ #QC_P"^11]6\P_M]_R?B?*_E2?\\W_[Y-'E2?\
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M<YX)'.*FD\,LMW/9PW8N+FW3S)(HHB3CC[O][K^E1R2-_K=+N8]I_P ?MO\
M]=5_F*^J$^XOTKY9B18]3C17WJLR@-C&?FZXKZE3[B_05U8;J?/Y^[RIOR8Z
MBBBNL^:"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** .#^+?_(EC_KZC_K7BEG<BTG,IA67*,H#,0!D$9X]C7M7Q;/\
MQ1?_ &]1_P!:\,W#U%<%?2>A]CDJ4L*T^[-NV\37D%QIDKJDW]G*5@5B0/QQ
MUQG%.M/$0M(8T_L^)BC3$-YC#(D!!!]<9X-86X>HHW#U%8\\CU'A:+Z&NVNN
MT1C^R1!39?81\[<)Z_6I+SQ#]LMKJ-[&)7NA%YSAV^8IT(';I6)N'J*-P]11
MSR#ZK1O>QN-XC,EU>SR6,):Z$><.PVE,8P>N#CD4Z]\1KJ"2+<:; S"9YH6+
MMF(ORP_VAGG!K!W#U%&X>HHYY!]5HW3M^/\ P3:@U_RH[57LXY/)MGM&)<C?
M&V>/8\]:)?$#20O$+*)4:T6SX=N$!R#]<@5B[AZBC</44<\@^K4;WL:LNL)<
M6%M!/8Q27%O%Y,=P6(.SL"O0D9X-+-K;3ZI+J!@$4T@7!BD(*,N.5/X5D[AZ
MBC</44<TBOJ]+L7GNY+_ %L7<@4/-<!V"C R37U GW%^E?*]HP^VV_(_UJ_S
M%?5"?<7Z5U8;J?.9ZDG32[,=11176?-A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% $4]M#<Q^7/$DJ9SM=01G\:K_V
M/IO_ $#[7_ORO^%7:*5D-2:V92_L?3?^@?:_]^5_PH_L?3?^@?:_]^5_PJ[1
M19#YY=RE_8^F_P#0/M?^_*_X4?V/IO\ T#[7_ORO^%7:*+(.>7<I?V/IO_0/
MM?\ ORO^%']CZ;_T#[7_ +\K_A5VBBR#GEW*7]CZ;_T#[7_ORO\ A1_8^F_]
M ^U_[\K_ (5=HHL@YY=RE_8^F_\ 0/M?^_*_X4?V/IO_ $#[7_ORO^%7:*+(
M.>7<I#2-.!R+"U!'0^2O^%7>U%%.PFV]PHHHH$%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OBCQ OAG0Y=3> SK&
MRKL#8)R<=:X+_A=EO_T!9?\ O\/\*W/BX^SX>WC>DL?_ *%7SE]J]ZY:LY1E
M9'O9;A*%:DY5%=W/<?\ A=EO_P! 67_O\/\ "C_A=EO_ - :7_O\/\*\6LTN
M-0G\FV3>X4N<L %4=22> /<TZ]AN=/:(7*JHE3?&RN&5USC((.#67M:AZ/U#
M!7Y>77U/9_\ A=EO_P! 67_O\/\ "C_A=EO_ - 67_O\/\*\6MTN+J"YGA3?
M';)YDS9'RKG&?SJO]J![T>UJ=Q_V?@_Y?Q9[C_PNRW_Z TO_ '^'^%'_  NR
MW_Z LO\ W^'^%>0)I>HO;"X6$;3$9@ID4/Y8_CVYSCWQ6;]K![T>UJ"6 P4M
MH_B>X_\ "[+?_H"R_P#?X?X4?\+LM_\ H"R_]_A_A7AXNMQPIR?04GVL?WJ/
M:U.X_P"SL'_+^+/<?^%V6_\ T!9?^_P_PH_X79;_ /0%E_[_  _PKP[[6/[W
MZT?:AZT>UGW#^SL'_+^+/<1\:X"P']C2\G'^N'^%>K*=R ^HS7QTEU^\3G^(
M?SK[$C_U2?[HKHHSE*]SQLSP]&BX^R5KW'4445N>0%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_ !G./AM>G_IK
M%_Z%7S#YI]:^F_C4<?#*^/\ TUB_]"%?-6AV<&JZW:6%Q<M;13R!&F";MF>^
M,C-<U6-Y'MX"KR4GZFQX3O;^SO[F[L[.*^2.V875I(,B6%B PP.>XZ5TTVC:
M>]TBV$,QCO=%N;BWTVY.Z6UE&<*O<Y()'>N>M?"-Y'X_/AM[TVVV4*UXH./+
M)&UQ@\YRN!GJ15"YTG5?[8NQ9?:[HV]S) +GD.[)G..<YP,X!Z5*5D;3J*<K
MIVT.TAA;3+2Y>"RC6YE\-Q2M&8]V^3S5R2O<\5@^(ET:6_$LLQL+E[*&26WM
MK<,GG%,L/O#;SCCGJ:Q(M)\0-:C4HK:[\H0F83!L$QC@L.<D=<XJM+I6J+YT
MDEG-^[C6>1CV1_NL?8Y'-#5^@H-1E?F._MHSJUA]@U>U:RU"PTTR6>L0'$<D
M(3*I)V(*G /7FL@'3Y_"=KK$<-LMQ;JUC-;XQYDK'*28_P!W.3Z@52U/P_?6
M&GP6I>^EN)+>.Z9 X,"QL,\\\%<J,]#FJ]U;ZMJ7E:7;:(MLULRQR10J09)B
M.IR>6('04["C/LSMK&U@&NZ?<V,:*CM<0FSG@ E@E$)^4'HZ9Y!'.36:EDMC
MX?L[C^Q7O8;RRE^TR955AGR?O'&4*X'&1Q7+?V'K[6VGWBQ3R-=%Q;!9,N"A
MYP,Y'0_E5>WTW7;N!!;VUW+#<JTP"$E9 I^9CSC@]2:/D%_[QW5V(8+?54BT
MVS M]&M;J+$ ^68[-S>YY;BN7\91QVOB200Q)$DD$$I5!A=S1*6P.W)-9W]D
M:Z7N%%M<E[?>)5#Y(V?>[\@9YQFB70=<%O'<36%P(G7<KR'^'&[/)X&.<]*3
M5UL73FH2OS%2.4^8G/\ $/YU]M1_ZI/]T5\020S6EX()T*2*RY4^^"/TK[?C
M_P!6OT%:45:YQ9C4Y^4=1116YY04444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!YW\;CCX8WW_76+_T(5\T>'Y[2WUNV
MGO;@P6\;$LXC+GIZ"OI;XWG_ (M???\ 76+_ -"%?*6ZLI;G=AW[C1Z';>-+
M"23PY]K+QW%C-&E[>A"3-;Q/NB 7KG'\A4^D>(/#MIK<NH2ZE+G^U9IP)+=V
M7R9 <,B]%;)Y)YP!BO-=U&ZD:<J/0;+7]%MDTN-]0D86FE7=H["W?&^0OMQ[
M?,.?:DGUS1)=)NF&H.+BXT2"Q$'V=ODDC*YRW3!V\&O/]U&ZBX<J.\FU;0;F
M^RVHR"-=&AM5)@<1M-&JC#J.67@D=LXS5WQ!KOA[78YA'J\MI-%<I=PRK;-^
M\_<HA3 ^ZP*<'IS7FVZDW4!RH[_1_$6D6G_",7$]S*KZ=<7 N(S&6;9(Q(?/
M0XSR.M36FMZ%8Z%#IBZO([Q6-];&1+9PK-*V4(]J\[W4;J :3.ZM=?L4\.:8
M8=8FT_4+"*:"2)+?<TZNQ.4?MD,0<T3^)+2/Q%:7]C?JRQ:7';.MS;EHY&5
MIC=3U5N>:X7=2;J!V1M:W<:?<^(99M*B,-FS(8XR20IP-P&>=N<XSVQ7VO'_
J *M?H*^$8C^^3_>'\Z^[D_U:_05<#GQ#O9#J***LY HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
